A New Jersey federal judge has ordered a 30-day stay on his previous ruling that certain patents covering Teva-brand asthma inhalers were improperly listed in the federal Orange Book. The judge indicated his decision aims to allow the matter to reach the Third Circuit in the most orderly manner possible. For more details on this developing legal situation, visit the full article on Law360.